GoldBamboo.com - Knowledge is strong medicine
  

AstraZeneca explores 2nd-line therapy for lung cancer; to start Zactima 4th phase III trials - News


  Not Signed In - Sign In / Register




General Topics A-Z

AstraZeneca explores 2nd-line therapy for lung cancer; to start Zactima 4th phase III trials

Tue, 27 Feb 2007 12:13 PM EST

... NEW YORK: Leading drug maker AstraZeneca PLC said it would begin clinical trials of its experimental drug Zactima (generic name: vandetanib) on late-stage lung cancer patients in 20 countries to determine and compare its efficacy when taken with chemotherapy drug Alimta. ...

Related Topics

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource

July 25, 2008


Page Updated: June 12, 2007
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.